Abbott P/E Ratio
Current P/E Ratio
35.79
High Valuation
Very High - High growth expectations or significantly overvalued
Abbott (ABBOTINDIA) P/E ratio is 35.79 (High), EPS (TTM) ₹730.36, current price ₹25595.00 on NSE — Very High - High growth expectations or significantly overvalued. For live price, revenue and the complete fundamental profile, see Abbott share price chart.
Current Valuation Metrics
P/E Ratio
35.79
Current Price
₹25595.00
EPS (TTM)
₹730.36
Exchange
NSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
54.86
Sector Median
30.68
Sector Rank
#11 of 194
Sector Percentile
5.7%
ABBOTINDIA P/E Ratio — Valuation Signal & Historical Context
Abbott P/E 35.79 — signal: Overvalued. Analyse ABBOTINDIA shareholder distribution to track promoter, FII and institutional holdings.
- Stock appears overvalued with PE of 35.79, suggesting caution for new investments
- Trading at discount to sector average PE of 54.86
ABBOTINDIA vs Healthcare Peers — P/E Ratio Comparison
Abbott P/E 35.79 vs Healthcare average 54.86, median 30.68 — range 2.86–879.0.
Sector Average
54.86
Sector Median
30.68
Lowest P/E
2.86
Highest P/E
879.0
Companies
194
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Sunrest Lifescience | SUNREST | 3.5 | ₹30 | Low |
| Phaarmasia | PHRMASI | 4.06 | ₹68 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.97 | ₹7,724 | Low |
| Shelter Pharma | SHELTER | 5.34 | ₹49 | Low |
| Mono Pharmacare | MONOPHARMA | 6.25 | ₹20 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹77 | Low |
| Amwill Health Care | AMWILL | 7.81 | ₹89 | Low |
| Brooks Laboratories | BROOKS | 8.06 | ₹206 | Low |
| Royal Sense | ROYAL | 8.24 | ₹59 | Low |